[How much does the choice of new oral anticoagulant matter for reducing the burden of stroke in atrial fibrillation?].
作者信息
Aguiar Carlos
机构信息
Serviço de Cardiologia, Hospital Santa Cruz, Centro Hospitalar de Lisboa Ocidental, Carnaxide, Portugal.
出版信息
Rev Port Cardiol. 2016 Mar;35(3):149-51. doi: 10.1016/j.repc.2016.02.002. Epub 2016 Feb 28.
PMID:26935753
Abstract
摘要
相似文献
1
[How much does the choice of new oral anticoagulant matter for reducing the burden of stroke in atrial fibrillation?].[新型口服抗凝药的选择对减轻心房颤动中风负担有多大影响？]
Rev Port Cardiol. 2016 Mar;35(3):149-51. doi: 10.1016/j.repc.2016.02.002. Epub 2016 Feb 28.
2
Review of challenges in optimizing oral anticoagulation therapy for stroke prevention in atrial fibrillation.房颤患者卒中预防中优化口服抗凝治疗所面临的挑战综述。
Am J Cardiovasc Drugs. 2013 Apr;13(2):87-102. doi: 10.1007/s40256-013-0016-5.
3
Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study.心房颤动卒中后抗凝治疗的三个月风险效益概况：SAMURAI-非瓣膜性心房颤动（NVAF）研究
Int J Stroke. 2016 Jul;11(5):565-74. doi: 10.1177/1747493016632239. Epub 2016 Feb 29.
4
Trends in oral anticoagulant choice for acute stroke patients with nonvalvular atrial fibrillation in Japan: the SAMURAI-NVAF study.日本非瓣膜性心房颤动急性卒中患者口服抗凝剂选择的趋势：SAMURAI-NVAF研究
Int J Stroke. 2015 Aug;10(6):836-42. doi: 10.1111/ijs.12452. Epub 2015 Jan 12.
5
Anticoagulant therapy in atrial fibrillation: vitamin K antagonists or novel oral anticoagulant drugs?心房颤动的抗凝治疗：维生素K拮抗剂还是新型口服抗凝药物？
J Cardiovasc Med (Hagerstown). 2015 Feb;16(2):139-41. doi: 10.2459/JCM.0000000000000212.
6
Selection of Oral Anticoagulants in Ischemic Stroke Patients with Nonvalvular Atrial Fibrillation.非瓣膜性心房颤动缺血性卒中患者口服抗凝剂的选择
J Stroke Cerebrovasc Dis. 2018 Oct;27(10):2627-2631. doi: 10.1016/j.jstrokecerebrovasdis.2018.05.036. Epub 2018 Jun 30.
7
Progress for stroke prevention with atrial fibrillation: emergence of alternative oral anticoagulants.心房颤动卒中预防的进展：新型口服抗凝药的出现
Stroke. 2012 Apr;43(4):1179-85. doi: 10.1161/STROKEAHA.111.639864.
8
Anticoagulation for Stroke Prevention in Atrial Fibrillation.心房颤动卒中预防的抗凝治疗。
Nurs Clin North Am. 2023 Sep;58(3):379-387. doi: 10.1016/j.cnur.2023.05.005. Epub 2023 Jun 16.
9
Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation.反对观点：“华法林应是老年房颤患者血栓预防的首选药物”。关于老年房颤患者使用口服抗凝治疗的注意事项。
Thromb Haemost. 2008 Jul;100(1):16-7. doi: 10.1160/TH08-06-0343.
10
Oral anticoagulants for stroke prevention in atrial fibrillation. Foreword.用于心房颤动中风预防的口服抗凝剂。前言。
Curr Probl Cardiol. 2014 Sep;39(9):317. doi: 10.1016/j.cpcardiol.2014.07.002. Epub 2014 Jul 16.
Zotero 插件